Phase 2
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Colorectal Neoplasms
Both
Colorectal Neoplasms
Trial Information
Inclusion Criteria
- Patients with metastatic colorectal adenocarcinoma who have failed one prior course
of chemotherapy.
- Patients must have at least one measurable tumor.
- Patients may not have received prior treatment with oxaliplatin.
Type of Study:
Interventional
Study Design:
Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
TEZ101
NCT ID:
NCT00051688
Start Date:
June 2003
Completion Date:
August 2004
Related Keywords:
- Colorectal Neoplasms
- Neoplasms
- Colorectal Neoplasms
Name | Location |
|---|---|
| USC/Norris Comprehensive Cancer Center | Los Angeles, California 90033-0800 |
| Comprehensive Cancer Centers of the Desert | Palm Springs, California 92262 |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa, Florida 33612 |
| Kansas City Oncology and Hematology Group | Kansas City, Missouri 64111 |
| Georgetown University Medical Center, Lombardi Cancer Center | Washington, District of Columbia 20007 |
| Cancer Institute Medical Group | Los Angeles, California 90025 |
| ACRC/Arizona Clinical Research Center | Tucson, Arizona 85712 |
| Northwestern University Feinberg School of Medicine | Chicago, Illinois 60611 |
